Pharmacometabolomic study of drug response to antihypertensive medications for hypertension marker identification in Han Chinese individuals in Taiwan.
Comput Struct Biotechnol J
; 20: 6458-6466, 2022.
Article
in En
| MEDLINE
| ID: mdl-36467587
ACEi, Angiotensin-Converting Enzyme inhibitor; ADME, Absorption, Distribution, Metabolism, and Excretion; ANCOVA, Analysis of Covariance; ARB, Angiotensin Receptor Blocker; Antihypertensive drugs; BMI, Body Mass Index; CCB, Calcium Channel Blocker; DG, Diglycerides; DIUR, Diuretics; Diacylglycerol; FDR, False Discovery Rate; HMDB, Human Metabolome Database; LC-MS, Liquid Chromatography-Mass Spectrometry; Liquid chromatography-mass spectrometry; LysoPC, Lysophosphatidylcholine; Lysophosphatidylcholine; Oleamide; Pharmacometabolomics; RT, Retention Time; SMART, Statistical Metabolomics Analysis An R Tool
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Diagnostic_studies
/
Prognostic_studies
Language:
En
Journal:
Comput Struct Biotechnol J
Year:
2022
Document type:
Article
Affiliation country:
Taiwán
Country of publication:
Países Bajos